Ocrevus 300 MG/10 ML vial 10ML

Ended Awarded

Contract number
SPE2DB23FJQ14
Awardee
Awarding agency
Obligated
$113,094

Award facts

Contract value 100% obligated
$113,093.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $113,093.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The contract has a period of performance from August 6, 2023 through August 25, 2023, with performance taking place in Conshohocken, Pennsylvania. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and this order is likely supporting that agency's medical logistics programs.

Quick answers

Who was awarded contract SPE2DB23FJQ14?

SPE2DB23FJQ14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2023.

How much is contract SPE2DB23FJQ14 worth?

The government has obligated $113,094 on SPE2DB23FJQ14.

Is contract SPE2DB23FJQ14 an order under another contract?

Yes. SPE2DB23FJQ14 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.

Was contract SPE2DB23FJQ14 competed?

The extent of competition for SPE2DB23FJQ14 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award